Oxylan 80mg prolonged-release tablets (G.L. Pharma UK Ltd)
BNF presentation 0407020ADBFAEAI within chapter Central Nervous System. Analyse prescribing behaviour, spending pressure, and high-usage pharmacies.
Product
Chemical substance
Chapter
Presentation code
0407020ADBFAEAI
Usage overview
Total items and spend derived from NHS dispensing data.
Items dispensed
36
NHS spend (£)
£1,918.67
Recent activity
March 2025
Monitor this presentation to understand cost pressures, availability challenges, and opportunities for clinical optimisation.
Dispensing trend
Month-by-month national usage.
| Month | Items dispensed |
|---|---|
| March 2025 | 12 |
| December 2024 | 1 |
| November 2024 | 9 |
| October 2024 | 7 |
| August 2024 | 1 |
| July 2024 | 6 |
Top pharmacies dispensing this medicine
Identify providers with the highest utilisation to focus engagement and support.
| Pharmacy | Items | Region |
|---|---|---|
| Unknown pharmacy | 7 | No data available |
| Unknown pharmacy | 5 | No data available |
|
Asa Medical Group
ODS C86609
|
3 | 02X - SOUTH YORKSHIRE ICB |
| Unknown pharmacy | 3 | No data available |
|
Dordon & Polesworth Group Practice
ODS M84007
|
3 | B2M3M - COVENTRY AND WARWICKSHIRE ICB |
| Unknown pharmacy | 2 | No data available |
| Unknown pharmacy | 2 | No data available |
| Unknown pharmacy | 1 | No data available |
| Unknown pharmacy | 1 | No data available |
| Unknown pharmacy | 1 | No data available |